Get started

Adial Pharmaceuticals, Inc

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

ADIL chart

Key stats

Market capitalization
3.069MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−9.84USD
Net income
−12.731MUSD
Revenue
—
Shares float
1.218M
Beta
0.98

About Adial Pharmaceuticals, Inc

Sector
Health Technology
CEO
Cary J. Claiborne
Headquarters
Charlottesville
Website
adialpharma.com
Employees
20
Founded
2010
ISIN
US00688A2050

Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. Its lead product is AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson & William B. Stilley in November 2010 and is headquartered in Charlottesville, VA.

Ideas

ADIL - Retrace To Support - Good Entry?ADIAL saw an increase in volume and runup to 3.30 after which we saw a retrace to the 2.18 support level that held nicely. The upward trendline has been holding consistently on the daily and weekly charts. I am looking for a bullish engulfing or gap up opening with retrace to higher low to confirm t
Long
3
$ADIL is gonna to fall todayPupm&Dump trading strategy idea. $ADIL is rising without clear preconditions today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $2,10; stop-loss — $2,35. take-profit — $1,
ADIL: Next Target is $1.75 --> Bullish SupportFirst off, please don't take anything I say seriously or as financial advice. As always, this is on an opinion based basis. That being said, I am keeping a close watch on ADIL. It seems to have continued bullish support and looks like it can continue on a positive run all the until way next week for
Long
Insider confidence in Adial Pharmaceuticals bodes wellAs Adial Pharmaceuticals advances its Phase 3 clinical trial of AD04 for the treatment of alcohol use, insiders are showing confidence in the company. Today they appointed Mark Howard Peikin as chief strategy officer, and he took the position without a salary. Instead, he accepted a stock option as
Long
ADIL10:09 AM EDT, 09/11/2019 (MT Newswires) -- Adial Pharmaceuticals (ADIL) said Wednesday that it has successfully retested a previously manufactured supply of clinical trial packaged tablets of the investigational drug AD04 for the treatment of alcohol use disorder. The company said tests showed that
Long
ADIL pattern ADIL has less of the pattern to follow the historicals but as far as it's in the wedge pattern, this is a good time to add to the dips. I've been watching the channel and trading it but hard for me to gauge a breakout. Any news could be the catalyst and we could see a good July.

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
Total revenue
Gross profit
EBITDA
EBIT
Net income
‪0%‬
‪0%‬
‪0%‬
‪0%‬
‪0%‬
Debt level and coverage
Earnings
Next:—
‪0‬

Trading & brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.3Good
Learn more

See all brokers